Latest Breaking News On - March where - Page 9 : comparemela.com

5 questions answered about Johnson & Johnson s COVID-19 vaccine Share Updated: 12:39 PM PST Feb 25, 2021 Jen Christensen, CNN Share Updated: 12:39 PM PST Feb 25, 2021 Hide Transcript Show Transcript WITH AN FDA ADVISORY PANEL VOTE SET FOR FRIDAY, WE ARE ONE STEP CLOSER TO FEDERAL APPROVAL OF THE JOHNSON AND JOHNSON VACCINE. HOW DOES IT COMPARE TO MODERNA AND PFIZER? THE MOST IMPORTANT THING ABOUT IT IS THAT IT’S A LOT EASIER TO USE. IT’S A SINGLE DOSE VACCINE. KAI: DR. SEBASTIAN RUHS THE CHIEF MEDICAL OFFICER FOR CHASE BRAXTON HEALTHCARE EXPLAINED, THAT MEANS THE JOHNSON AND JOHNSON VACCINE REACHES ITS MAXIMUM EFFICACY AFTER JUST ONE DOSE. JOHNSON AND JOHNSON TRIALS SHOWED A 72% OVERALL EFFICACY RATE IN THE U.S.MODERNA AND IN THE U.S.. MODERNA AND PFIZER RATES ARE HIGHER. THESE VACCINES WERE APPROVED AT DIFFERENT TIMES. KAI: DR. RUHS SAYS THE NUMBERS SHOULDN’T SWAY PEOPLE ONE WAY OR THE OTHER. IF THE MODERNA AND PFIZER WOULD H

United statesNew yorkWhite houseDistrict of columbiaScott shermanJeff carsonUs centers for diseaseDrug administrationHealth sciences of rutgers universityPrevention advisory committee on immunization practicesProducts advisory committeeRelated biological products advisory committeeSaturday on sundayDisease controlAdvisory committeeImmunization practices